SARS-CoV-2 Spike RBD (receptor binding domain), 513-520-Lys(Biotin-LC)

This peptide sequence represents residues 513-520 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.

Online Inquiry

CAT#S29020
SequenceOne Letter Code: LSFELLHA-K(Biotin-LC)-NH2
Three-Letter Code: H-Leu-Ser-Phe-Glu-Leu-Leu-His-Ala-Lys(Biotin-LC)-NH2
Purity95%
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

An overview of Tripeptide-10 Citrulline  Signal oligopeptides are commonly synthesized from portions of EMPs and from natural ...

 PAC-113, as well as a new type of Trp-rich peptide, is a 12 amino-acid fragment of the saliva protein histatin 5 ...

 Guangxitoxin 1E is a KV2.1 and KV2.2 specific channel blocker (IC50 values are 1-3 nM). The experimental results ...

Peptides are compounds formed by linking α-amino acids by peptide bonds, and are intermediate products of proteolysis. They a ...

Basic information Desmopressin is a synthetic analogue of the antidiuretic hormone vasopressin used in the treatment of centr ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.